The effects of metabolic diseases on the cardiovascular system
- PMID: 3333140
The effects of metabolic diseases on the cardiovascular system
Abstract
Many metabolic diseases result in pathological changes within the cardiovascular system, often with the most severe effects on the function of the heart and great vessels. Metabolic disorders affecting the heart include disorders of amino acid metabolism, storage diseases, neuromuscular diseases, diseases of metal and pigment metabolism, carnitine deficiency, and connective tissue disorders. Several inborn errors of metabolism may involve the myocardium due to the accumulation of abnormal metabolites in the myocardial cells. In addition, the heart valves and coronary vessels may be involved. If the predominant effect is in the myocardial cell, it will be manifested clinically as a cardiomyopathy. Some disorders, in particular oxalosis, may involve the conduction system as a result of the deposition of oxalate crystals and result in conduction disturbances such as in alkaptonuria, primary oxalosis, and homocystinuria. Myocardial involvement may result in cardiomyopathy of the three functional types: (1) congestive, as in Fabry's disease, (2) hypertrophic, as in glycogen storage disease, type II, or (3) restrictive, as in Gaucher's disease. In the storage disease severe valvular as well as myocardial involvement occur predominantly in the glycogen storage diseases, types II-IV, mucolipidoses, sphingolipidoses, and neuronal ceroid lipofuscinosis. There are a variety of neuromuscular disorders that may be associated with cardiomyopathy, including the muscular dystrophies, Friedreich's ataxia, and Kugelberg-Welander syndrome. The pathological features of these conditions are not specific, but result usually in a congestive form of cardiomyopathy. Patients with metal and pigment metabolic disorders include iron storage disease, either hemochromatosis or transfusional hemosiderosis, Menkes' kinky hair syndrome, and Dubin-Johnson syndrome. Either a restrictive or a congestive form of cardiomyopathy may occur. The systemic form of carnitine deficiency is an autosomal recessive disorder and may present as a cardiomyopathy with congestive heart failure and lipid accumulation in the myocardial cells. Connective tissue disorders are generalized diseases that may involve the heart and valvular tissue, but also the blood vessels. These include Marfan's syndrome, Ehlers-Danlos syndrome, osteogenesis imperfecta, and pseudo-xanthoma elasticum.
Similar articles
-
Review: Metabolic cardiomyopathy and conduction system defects in children.Ann Clin Lab Sci. 2004 Winter;34(1):15-34. Ann Clin Lab Sci. 2004. PMID: 15038665 Review.
-
[Metabolic disorders and corneal changes (author's transl)].Klin Monbl Augenheilkd. 1981 Jun;178(6):419-23. Klin Monbl Augenheilkd. 1981. PMID: 6973662 German.
-
Cardiovascular involvement in metabolic diseases.Pediatr Pathol Mol Med. 2002 Mar-Apr;21(2):93-136. doi: 10.1080/15227950252852050. Pediatr Pathol Mol Med. 2002. PMID: 11942539 Review.
-
Laboratory diagnosis of the neuromuscular glycogen storage diseases.Ann Clin Lab Sci. 1982 Nov-Dec;12(6):431-8. Ann Clin Lab Sci. 1982. PMID: 6817693 Review.
-
Metabolic myopathies: update 2009.J Clin Neuromuscul Dis. 2009 Mar;10(3):97-121. doi: 10.1097/CND.0b013e3181903126. J Clin Neuromuscul Dis. 2009. PMID: 19258857 Review.
Cited by
-
Delineating the role of alterations in lipid metabolism to the pathogenesis of inherited skeletal and cardiac muscle disorders: Thematic Review Series: Genetics of Human Lipid Diseases.J Lipid Res. 2012 Jan;53(1):4-27. doi: 10.1194/jlr.R012120. Epub 2011 Nov 7. J Lipid Res. 2012. PMID: 22065858 Free PMC article. Review.
-
Structural and functional cardiac analyses using modern and sensitive myocardial techniques in adult Pompe disease.Int J Cardiovasc Imaging. 2015 Jun;31(5):947-56. doi: 10.1007/s10554-015-0629-7. Epub 2015 Mar 6. Int J Cardiovasc Imaging. 2015. PMID: 25744427
Publication types
MeSH terms
LinkOut - more resources
Medical